Sayaka Maeda

2.2k total citations
52 papers, 1.4k citations indexed

About

Sayaka Maeda is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Sayaka Maeda has authored 52 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Biochemistry, 13 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Epidemiology. Recurrent topics in Sayaka Maeda's work include Advanced Glycation End Products research (15 papers), Chronic Kidney Disease and Diabetes (6 papers) and Natural Antidiabetic Agents Studies (6 papers). Sayaka Maeda is often cited by papers focused on Advanced Glycation End Products research (15 papers), Chronic Kidney Disease and Diabetes (6 papers) and Natural Antidiabetic Agents Studies (6 papers). Sayaka Maeda collaborates with scholars based in Japan, United States and China. Sayaka Maeda's co-authors include Sho‐ichi Yamagishi, Takanori Matsui, Masayoshi Takeuchi, Kei Fukami, Yuji Ishibashi, Ayako Ojima, Yuri Nishino, Seiji Ueda, Seiya Okuda and Yuichiro Higashimoto and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sayaka Maeda

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sayaka Maeda Japan	21	506	395	297	231	189	52	1.4k
Chang‐Hsun Hsieh Taiwan	21	467 0.9×	78 0.2×	425 1.4×	243 1.1×	177 0.9×	88	1.5k
Britt Hofmann Germany	24	167 0.3×	238 0.6×	392 1.3×	124 0.5×	197 1.0×	107	1.4k
Hiroshi Sakura Japan	17	444 0.9×	230 0.6×	1.2k 4.1×	140 0.6×	653 3.5×	63	2.1k
Naziha Kaabachi Tunisia	21	276 0.5×	173 0.4×	222 0.7×	219 0.9×	139 0.7×	125	1.6k
Neil Dalton United Kingdom	22	191 0.4×	236 0.6×	265 0.9×	78 0.3×	135 0.7×	53	1.3k
Sarantis Livadas Greece	31	725 1.4×	137 0.3×	391 1.3×	213 0.9×	194 1.0×	98	2.4k
Tommaso de Giorgis Italy	18	313 0.6×	95 0.2×	311 1.0×	296 1.3×	93 0.5×	31	1.5k
John Alcolado United Kingdom	17	420 0.8×	217 0.5×	562 1.9×	116 0.5×	361 1.9×	45	1.5k
Michal Anděl Czechia	28	481 1.0×	84 0.2×	598 2.0×	201 0.9×	595 3.1×	118	2.2k
Moon Gi Choi South Korea	24	375 0.7×	59 0.1×	583 2.0×	202 0.9×	198 1.0×	118	1.8k

Countries citing papers authored by Sayaka Maeda

Since Specialization

Citations

This map shows the geographic impact of Sayaka Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sayaka Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sayaka Maeda more than expected).

Fields of papers citing papers by Sayaka Maeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sayaka Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sayaka Maeda. The network helps show where Sayaka Maeda may publish in the future.

Co-authorship network of co-authors of Sayaka Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Sayaka Maeda. A scholar is included among the top collaborators of Sayaka Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sayaka Maeda. Sayaka Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maeda, Sayaka, Tatsuya Morita, Naosuke Yokomichi, et al.. (2023). Continuous Deep Sedation for Psycho-Existential Suffering: A Multicenter Nationwide Study. Journal of Palliative Medicine. 26(11). 1501–1509. 5 indexed citations

Maeda, Sayaka, Makoto Yamaguchi, Masaaki Nagai, et al.. (2019). Proton pump inhibitor use increases the risk of peritonitis in peritoneal dialysis patients. PLoS ONE. 14(11). e0224859–e0224859. 18 indexed citations

Maeda, Sayaka, Tatsuya Morita, Masayuki Ikenaga, et al.. (2018). Changes in opinions on palliative sedation of palliative care specialists over 16 years and their effects on clinical practice. Supportive Care in Cancer. 27(6). 2211–2219. 10 indexed citations

Ojima, Ayako, Takanori Matsui, Sayaka Maeda, et al.. (2014). DNA aptamer raised against advanced glycation end products inhibits melanoma growth in nude mice. Laboratory Investigation. 94(4). 422–429. 37 indexed citations

Matsui, Takanori, Yuri Nishino, Ayako Ojima, et al.. (2014). Pigment Epithelium–Derived Factor Improves Metabolic Derangements and Ameliorates Dysregulation of Adipocytokines in Obese Type 2 Diabetic Rats. American Journal Of Pathology. 184(4). 1094–1103. 23 indexed citations

Maeda, Sayaka, Takanori Matsui, Ayako Ojima, Masayoshi Takeuchi, & Sho‐ichi Yamagishi. (2014). Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products. Nutrition Research. 34(9). 807–813. 35 indexed citations

Ishibashi, Yuji, Takanori Matsui, Sayaka Maeda, Yuichiro Higashimoto, & Sho‐ichi Yamagishi. (2013). Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor. Cardiovascular Diabetology. 12(1). 125–125. 145 indexed citations

Maeda, Satoshi, Sho‐ichi Yamagishi, Takanori Matsui, et al.. (2013). Beneficial Effects of Vildagliptin on Retinal Injury in Obese Type 2 Diabetic Rats. Ophthalmic Research. 50(4). 221–226. 27 indexed citations

Hyogo, Hideyuki, Sho‐ichi Yamagishi, Sayaka Maeda, et al.. (2012). Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. Digestive and Liver Disease. 44(6). 492–496. 43 indexed citations

10.

Hyogo, Hideyuki, Sho‐ichi Yamagishi, Sayaka Maeda, et al.. (2012). Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease. Clinical Biochemistry. 45(18). 1554–1557. 4 indexed citations

11.

Hyogo, Hideyuki, Sho‐ichi Yamagishi, Sayaka Maeda, et al.. (2012). Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. Clinical and Experimental Medicine. 14(1). 45–51. 3 indexed citations

12.

Hyogo, Hideyuki, Sho‐ichi Yamagishi, Sayaka Maeda, et al.. (2012). Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance. Digestive and Liver Disease. 44(11). 935–939. 6 indexed citations

13.

Nakamura, Tsukasa, Eiichi Sato, Nobuharu Fujiwara, et al.. (2011). Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clinical Biochemistry. 44(8-9). 601–604. 63 indexed citations

14.

Yamagishi, Sho‐ichi, Sayaka Maeda, Takanori Matsui, et al.. (2011). Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes. Biochimica et Biophysica Acta (BBA) - General Subjects. 1820(5). 663–671. 230 indexed citations

15.

Maeda, Sayaka, et al.. (2008). Molecular cloning of ecdysone 20-hydroxylase and expression pattern of the enzyme during embryonic development of silkworm Bombyx mori. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 149(3). 507–516. 27 indexed citations

16.

Sonobe, Haruyuki, Tsuyoshi Ohira, Sayaka Maeda, et al.. (2006). Purification, Kinetic Characterization, and Molecular Cloning of a Novel Enzyme, Ecdysteroid 22-Kinase. Journal of Biological Chemistry. 281(40). 29513–29524. 24 indexed citations

17.

Ueda, Mitsuyoshi, Hiroshi Kinoshita, Sayaka Maeda, Wen Zou, & A. Tanaka. (2003). Structure-function study of the amino-terminal stretch of the catalase subunit molecule in oligomerization, heme binding, and activity expression. Applied Microbiology and Biotechnology. 61(5-6). 488–494. 14 indexed citations

18.

Kubo, H., R. W. Clay, S. Gunji, et al.. (2001). Data acquisition system of the CANGAROO-III telescope. CERN Document Server (European Organization for Nuclear Research). 7. 2900. 1 indexed citations

19.

Matsuoka, Mayumi, Sayaka Maeda, M. Kai, et al.. (2000). Mycobacterium leprae typing by genomic diversity and global distribution of genotypes.. PubMed. 68(2). 121–8. 61 indexed citations

20.

ISHIKAWA, Jiro, Sadao Kamidono, Sayaka Maeda, et al.. (1989). Solitary retroperitoneal neurofibroma: a case report.. PubMed. 35(7). 1157–60. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact